← Back to Intel
Insider ActivityAVTX
Sullivan Christopher Ryan, Chief Financial Officer at Avalo Therapeutics, Inc., sold $126K of AVTX
Updated Jun 10, 2026
Sullivan Christopher Ryan
Chief Financial Officer
Avalo Therapeutics, Inc. ·
$AVTX
Transaction Details
| Insider | Sullivan Christopher Ryan |
|---|---|
| Title | Chief Financial Officer |
| Company | Avalo Therapeutics, Inc. |
| Ticker | AVTX |
| Transaction Type | Sale |
| Transaction Date | 2026-04-01 |
| Shares Traded | 7,479 |
| Price Per Share | $16.8259 |
| Total Value | $126K |
| Filed Date | 2026-04-03 |
| Accession Number | 0001810417-26-000006 |
Ownership Context
| Shares Owned After Transaction | 25,318 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001810417-26-000006
Other Insider Trades — AVTX
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| KANTOFF AARON | Insider | traded | — | 2026-06-02 |
| Truex Samantha | Insider | traded | — | 2026-06-02 |
| Lind Kevin Robert | Insider | traded | — | 2026-06-02 |
| Jain Rita | Insider | traded | — | 2026-06-02 |
| Heffernan Michael Thomas | Insider | traded | — | 2026-06-02 |
| KAPLAN GILLA | Insider | traded | — | 2026-06-02 |
| Doyle Mittie | Chief Medical Officer | sold | $11K | 2026-05-28 |
| Doyle Mittie | Chief Medical Officer | traded | $5K | 2026-05-28 |
| Doyle Mittie | Chief Medical Officer | traded | — | 2026-05-21 |
| Sullivan Christopher Ryan | Chief Financial Officer | traded | — | 2026-05-21 |
Other Trades by Sullivan Christopher Ryan
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| AVTX | Avalo Therapeutics, Inc. | traded | — | 2026-05-21 |
| AVTX | Avalo Therapeutics, Inc. | traded | $184K | 2026-05-07 |
| AVTX | Avalo Therapeutics, Inc. | sold | $449K | 2026-05-07 |
| AVTX | Avalo Therapeutics, Inc. | sold | $257K | 2026-05-06 |
| AVTX | Avalo Therapeutics, Inc. | traded | $378K | 2026-05-06 |
| AVTX | Avalo Therapeutics, Inc. | sold | $238K | 2026-05-06 |
| AVTX | Avalo Therapeutics, Inc. | sold | $56K | 2026-05-06 |
| AVTX | Avalo Therapeutics, Inc. | sold | $197K | 2026-05-06 |
| AVTX | Avalo Therapeutics, Inc. | sold | $201K | 2026-05-06 |
| AVTX | Avalo Therapeutics, Inc. | sold | $112K | 2026-04-30 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for AVTX — Avalo Therapeutics, Inc. →
Track AVTX insider activity in real time on The Wire →
Get alerts when Sullivan Christopher Ryan files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 10, 2026 at 07:20 UTC